With $360M in New Financing, Guardant Health Prepares to Sequence One Million Cancer Patients
Guardant Health, based in Redwood, California, has secured $360 million in investor financing, making it the newest horse in the race to use liquid biopsy technology to significantly advance cancer testing and treatment. Guardant will use this round of financing to expand its work both nationally...